🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Omics Sequencing of Specimen Derived From Mother-Infant-Pairs

Recruitingn/aAges any - 40 YearsAllZhujiang Hospital
NCT05462366 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * healthy pregnant women aged between 20y and 40y. * Vaginal birth * BMI\<23.5 before pregnancy * Infants' birth weight, between 2500g and 4000g. Exclusion Criteria: * gestational diabetes * diagnosis of depressive disorder during pregnancy * gestational hypertension * diagnosis of other diseases during pregnancy * Under probiotics or antibiotic treatment from 3 months prior to pregnancy till 3 months after delivery * histrory of smoking and drinking alcohol * history of diarrhea from 3 months prior to pregnancy till 3 months after delivery
💊

What it tests

  • Sample collection
📍

Where

1 site
Zhujiang Hospital
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy